Back to search

Article

BioPathfinder: Evidence-guided multi-agent platform enables hypothesis discovery for CAR-T engineering

2026-07-16

Abstract excerpt

<h4>ABSTRACT</h4> Clinical studies of chimeric antigen receptor (CAR)-T therapy generate diverse molecular and clinical evidence that remains fragmented across publications, public repositories and patient-derived datasets, limiting systematic therapeutic discovery. Here we present BioPathfinder, an evidence-guided multi-agent workflow for closed-loop biomedical discovery. BioPathfinder constructs a provenance-aw...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
830e50ed-506e-5c25-86cc-bd07c367894b
DOI
10.64898/2026.07.15.738646
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BioPathfinder: Evidence-guided multi-agent platform enables hypothesis discovery for CAR-T engineeringDOI 10.64898/2026.07.15.738646
Select a neighboring publication to make it the new centre.